These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33070218)

  • 1. Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis.
    Bœuf-Gibot S; Pereira B; Imbert J; Kerroum H; Menini T; Lafarge E; De Carvalho M; Vorilhon P; Boussageon R; Vaillant-Roussel H
    Eur J Clin Pharmacol; 2021 Mar; 77(3):321-329. PubMed ID: 33070218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
    Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP
    PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews.
    Al-Gobari M; Al-Aqeel S; Gueyffier F; Burnand B
    BMJ Open; 2018 Jul; 8(7):e021108. PubMed ID: 30056380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose versus low-dose angiotensin converting enzyme inhibitors in heart failure: systematic review and meta-analysis.
    Migliavaca CB; Stein C; Colpani V; Eibel B; Bgeginski R; Simões MV; Rohde LE; Falavigna M
    Open Heart; 2020 Aug; 7(2):. PubMed ID: 32820054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
    Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC
    JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.
    Philbin EF; Rocco TA; Lindenmuth NW; Ulrich K; Jenkins PL
    Am J Med; 2000 Dec; 109(8):605-13. PubMed ID: 11099679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
    Savarese G; Edner M; Dahlström U; Perrone-Filardi P; Hage C; Cosentino F; Lund LH
    Int J Cardiol; 2015 Nov; 199():415-23. PubMed ID: 26247798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies.
    Fu M; Zhou J; Sun A; Zhang S; Zhang C; Zou Y; Fu M; Ge J
    Int J Cardiol; 2012 Feb; 155(1):33-8. PubMed ID: 21481482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Khan MS; Fonarow GC; Khan H; Greene SJ; Anker SD; Gheorghiade M; Butler J
    ESC Heart Fail; 2017 Nov; 4(4):402-408. PubMed ID: 28869332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.
    Beldhuis IE; Streng KW; Ter Maaten JM; Voors AA; van der Meer P; Rossignol P; McMurray JJ; Damman K
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28209765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
    Yoshikawa Y; Tamaki Y; Morimoto T; Yaku H; Yamamoto E; Inuzuka Y; Ozasa N; Kitai T; Nagao K; Sato Y; Kondo H; Tamura T; Nakagawa Y; Kuwahara K; Kato T; Kimura T
    PLoS One; 2020; 15(9):e0239100. PubMed ID: 32925953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
    Xie W; Zheng F; Song X; Zhong B; Yan L
    Int J Cardiol; 2016 Feb; 205():65-71. PubMed ID: 26720043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of ACE inhibitors in patients with chronic heart failure and/or ventricular dysfunction : meta-analysis of randomised clinical trials.
    Agustí A; Bonet S; Arnau JM; Vidal X; Laporte JR
    Drug Saf; 2003; 26(12):895-908. PubMed ID: 12959631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for heart failure with reduced ejection fraction and health-related quality of life: a systematic review and meta-analysis.
    Turgeon RD; Barry AR; Hawkins NM; Ellis UM
    Eur J Heart Fail; 2021 Apr; 23(4):578-589. PubMed ID: 33634543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neurohormonal antagonists on blood pressure in patients with heart failure with reduced ejection fraction (HFrEF): a systematic review protocol.
    Guggilla RK; Sowa PM; Jamiolkowski J; Sinnadurai S; Amin A; Kaminski KA
    Syst Rev; 2020 Aug; 9(1):194. PubMed ID: 32838804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
    Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.
    Garg R; Yusuf S
    JAMA; 1995 May; 273(18):1450-6. PubMed ID: 7654275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.